Buscar resultados de ensayos clínicos
Hyperparathyroidism, Secondary - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide Condición: Hyperparathyroidism, Secondary Fecha: 2013-08-28 Intervenciones: Drug: Etelcalcetide Etelcalcetide is provided as a sterile lyophilized powder to be reconstituted with s |
Completed |
Nombre del estudio: Safety, Tolerability and Pharmacokinetics of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism Condición: Hyperparathyroidism, Secondary Fecha: 2010-05-28 Intervenciones:
|
Completed |
Nombre del estudio: Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Condición: Hyperparathyroidism, Secondary Fecha: 2013-02-05 Intervenciones: Drug: Etelcalcetide Administered by bolus injection into the venous line of the dialysis circuit at the |
Completed |
Nombre del estudio: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis Condición: Hyperparathyroidism, Secondary Fecha: 2013-02-05 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Condición: Hyperparathyroidism, Secondary Fecha: 2013-02-07 Intervenciones:
|
Completed |
Nombre del estudio: Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis Condición: Hyperparathyroidism, Secondary Fecha: 2010-08-12 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis Condición: Hyperparathyroidism, Secondary Fecha: 2014-03-03 Intervenciones: Drug: AMG 416 Subjects will be administered IV AMG 416 at the end of their regular dialysis sessions on |
Completed |
Nombre del estudio: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis Condición: Secondary Hyperparathyroidism Fecha: 2014-05-14 Intervenciones: Drug: KHK7580 Oral administration |
Completed |
Nombre del estudio: Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism Condición: Secondary Hyperparathyroidism Fecha: 2006-03-27 Intervenciones: Drug: paricalcitol |
Completed |
Nombre del estudio: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis Condición: Secondary Hyperparathyroidism Fecha: 2014-04-29 Intervenciones:
|